Who We Are
There remains a significant worldwide unmet need for less invasive surgical options for patients struggling with Obesity, Type 2 diabetes, or undergoing colorectal surgery. At GI Windows Surgical, we are engineering the first fundamental breakthrough in surgical anastomotic technology that allows for less invasive surgery for both surgeons and patients.
The team is comprised of experienced individuals who have successfully demonstrated cross-functional expertise to bring paradigm-changing medical technologies to market.
Evaluation of Sutureless Anastomosis after Ileostomy Takedown Using The Self-Forming Magnet Anastomosis System in a Porcine Model
Link to our article- Click Here
Two Abstracts Accepted for Oral Presentations
Sutureless
End to End
Anastomosis by
Magnetic Compression
The GIW 21-002 clinical study is underway at select sites across the U.S.
If you are a patient between the ages of 18 and 80 planned to undergo a loop ileostomy reversal surgery and would like to be considered for the study, click here.
GIW Surgical Devices 21-002 is limited by U.S. law to investigational use and is not approved for sale or distribution in the U.S.
VISION. COMMITMENT. EXPERTISE.
OUR VISION
Engineering less Invasive Solutions for Surgeons and Patients
OUR MISSION
Our passion is to develop disruptive surgical innovation in the delivery of magnetic compression anastomosis, allowing clinicians to improve patient outcomes, reduce healthcare costs, and create new capabilities in healthcare.
Dr. Rudolf Buxhoeveden
Chief of Bariatric Surgery
Hospital Aleman
The GI Windows magnets are the first ones capable of creating a compression anastomosis, which, with the help of a common flexible endoscope in a mini-invasive way, could be performed anywhere in the digestive tract accessible by endoscopy. It generates a wide, permanent anastomosis of incredible technical simplicity. This has the potential to change the way we will perform digestive surgery in a not too distant future.
Dr. Christopher Thompson
Director of Endoscopy
Director, Bariatric Endoscopy
Fellowship Program
Professor, Harvard Medical School
Gastroenterology, Hepatology
and Endoscopy
Type 2 diabetes & obesity create a cascade of risks for patients as it relates to increased cardiac events and increased mortality in a respiratory virus.
Brian Tinkham
President & CEO
Technology to reshape the future of surgical anastomotic procedures and bring tangible benefits to patients and the healthcare system.
Our Investors
Financial Partners
